Untreated short-term course of major depression: a meta-analysis of outcomes from studies using wait-list control groups
J Affect Disord. 2001 Oct;66(2-3):139-46.
doi: 10.1016/s0165-0327(00)00304-9.
Authors
M A Posternak 1, I Miller
Affiliation
●1Department of Psychiatry and Human Behavior, Brown University School of Medicine, Rhode Island Hospital, 235 Plain St., Suite 501, Providence, RI 02905, USA. mposternak@lifespan.org
●
PMID:
11578666
●
DOI:
10.1016/s0165-0327(00)00304-9
Abstract
Introduction:
While the short-term response rates to antidepressant medication and placebo are well established, very little is known about the short-term course of untreated depression. Knowledge of the course of untreated depression can serve as a benchmark for assessing the true benefits of active treatment.
Method:
A meta-analysis was performed analyzing the outcomes of all psychotherapy studies that randomized adult outpatients with major depressive disorder to a wait-list control group.
Results:
Nineteen studies involving 221 subjects were reviewed. The mean decrease in Hamilton Rating Scale for Depression scores over 2-20 weeks was 11.9%, while the mean decrease in Beck Depression Inventory scores was 15.7%. Using a subsample of studies that reported individual outcomes, we estimated that 15 of 76 subjects (19.7%) improved to a degree comparable to what would be considered a positive response in antidepressant trials.
Conclusions:
In the short-term, depressive symptomatology can be expected to decrease by about 10-15% on average without treatment. As many as 20% of subjects who participate in a short-term antidepressant trial may experience a spontaneous remission.
Publication types
●
Meta-Analysis
MeSH terms
●
Adult
●
Benchmarking
●
Depressive Disorder, Major / diagnosis
●
Depressive Disorder, Major / psychology
●
Depressive Disorder, Major / therapy*
●
Follow-Up Studies
●
Humans
●
Psychotherapy, Brief*
●
Randomized Controlled Trials as Topic
●
Treatment Outcome
●
Waiting Lists